Early discontinuation is a big part of why the medications are less effective in the real world, Chhabra says
Hair loss Hair loss is a less common side effect reported with Mounjaro and is usually temporary
DPS, Dutch Protein Services
GLP-1 Receptor Agonist Market Key Takeaways Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Pfizer, Inc., Amgen, Inc., Innovent Biologics, Inc., PegBio Co., Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH Increasing prevalence of chronic diseases such as diabetes and obesity Increasing R&D activities for developing novel therapeutics Formulation advancements of oral GLP-1 receptor agonists Adverse effects associated with few GLP-1 agonist drugs Product recalls by market players With the increasing prevalence of diabetes and obesity, GLP-1 receptor agonists have become popular due to their effectiveness in glycemic control and weight reduction, offering a dual benefit in managing type 2 diabetes mellitus (T2DM)
However, oil cleansers are less appropriate if rosacea presents with acne-like pustules, where heavier oils may contribute to comedone formation
Standard protocols for foot-related tendon issues typically involve 0.25-0.5 mg daily via subcutaneous injection near the affected area for 4-8 weeks
